0001127602-23-010715.txt : 20230317
0001127602-23-010715.hdr.sgml : 20230317
20230317165315
ACCESSION NUMBER: 0001127602-23-010715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman William
CENTRAL INDEX KEY: 0001304099
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 23743454
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-03-15
0001531048
Inari Medical, Inc.
NARI
0001304099
Hoffman William
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
Common Stock
2023-03-15
4
M
0
25000
.428
A
1277540
D
Common Stock
2023-03-15
4
S
0
6589
62.38
D
1270951
D
Common Stock
2023-03-15
4
S
0
2964
63.38
D
1267987
D
Common Stock
2023-03-15
4
S
0
5447
64.18
D
1262540
D
Common Stock
2023-03-15
4
S
0
4006
62.34
D
1258534
D
Common Stock
2023-03-15
4
S
0
2092
63.23
D
1256442
D
Common Stock
2023-03-15
4
S
0
3902
64.17
D
1252540
D
Stock Options (Right to Buy)
.428
2023-03-15
4
M
0
25000
0
D
2028-05-03
Common Stock
25000
56479
D
The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
This transaction was executed in multiple trades at prices ranging from $61.86 to $62.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.86 to $63.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $63.93 to $64.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $61.81 to $62.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.81 to $63.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $63.82 to $64.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
2023-03-17